TrialMedicine2017

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.

Choung Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.